JAGUAR HEALTH, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
JAGUAR HEALTH, INC. (JAGX) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $116.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-19
- JAGUAR HEALTH, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $69.00K, a 11.54% decline year-over-year.
- JAGUAR HEALTH, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $47.00K, a 29.85% decline year-over-year.
- JAGUAR HEALTH, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $66.00K, a 42.61% decline year-over-year.
- JAGUAR HEALTH, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $78.00K, a 36.07% decline year-over-year.
- JAGUAR HEALTH, INC. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $289.00K, a 36.90% decline from fiscal 2024.
- JAGUAR HEALTH, INC. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $458.00K, a 22.13% increase from fiscal 2023.
- JAGUAR HEALTH, INC. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $375.00K, a 20.58% increase from fiscal 2022.
- JAGUAR HEALTH, INC. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $311.00K, a 230.85% increase from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $69.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | $116.00K 10-Q · filed 2026-08-19 | $182.00K derived: sum of 3 quarters · filed 2026-08-19 | $260.00K derived: sum of 4 quarters · filed 2026-08-19 |
| 2026-03-31 | $47.00K 10-Q · filed 2026-05-20 | $113.00K derived: sum of 2 quarters · filed 2026-05-20 | $191.00K derived: sum of 3 quarters · filed 2026-05-20 | $269.00K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-12-31 | $66.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-07 | $144.00K derived: sum of 2 quarters · filed 2026-04-07 | $222.00K derived: sum of 3 quarters · filed 2026-08-19 | $289.00K 10-K · filed 2026-04-07 |
| 2025-09-30 | $78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $156.00K derived: sum of 2 quarters · filed 2026-08-19 | $223.00K 10-Q · filed 2025-11-14 | $338.00K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | $78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | $145.00K 10-Q · filed 2026-08-19 | $260.00K derived: sum of 3 quarters · filed 2026-08-19 | $382.00K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-03-31 | $67.00K 10-Q · filed 2026-05-20 | $182.00K derived: sum of 2 quarters · filed 2026-05-20 | $304.00K derived: sum of 3 quarters · filed 2026-05-20 | $416.00K derived: sum of 4 quarters · filed 2026-05-20 |
| 2024-12-31 | $115.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-07 | $237.00K derived: sum of 2 quarters · filed 2026-04-07 | $349.00K derived: sum of 3 quarters · filed 2026-04-07 | $458.00K 10-K · filed 2026-04-07 |
| 2024-09-30 | $122.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $234.00K derived: sum of 2 quarters · filed 2025-11-14 | $343.00K 10-Q · filed 2025-11-14 | $432.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $112.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $221.00K 10-Q · filed 2025-08-14 | $310.00K derived: sum of 3 quarters · filed 2025-08-14 | $431.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $109.00K 10-Q · filed 2025-05-15 | $198.00K derived: sum of 2 quarters · filed 2025-05-15 | $319.00K derived: sum of 3 quarters · filed 2025-05-15 | $437.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $89.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $210.00K derived: sum of 2 quarters · filed 2025-03-31 | $328.00K derived: sum of 3 quarters · filed 2025-03-31 | $375.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $121.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $239.00K derived: sum of 2 quarters · filed 2024-11-13 | $286.00K 10-Q · filed 2024-11-13 | $389.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $118.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $165.00K 10-Q · filed 2024-08-13 | $268.00K derived: sum of 3 quarters · filed 2024-08-13 | $357.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $47.00K 10-Q · filed 2024-05-14 | $150.00K derived: sum of 2 quarters · filed 2024-05-14 | $239.00K derived: sum of 3 quarters · filed 2024-05-14 | $329.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $103.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $192.00K derived: sum of 2 quarters · filed 2024-04-01 | $282.00K derived: sum of 3 quarters · filed 2024-04-01 | $311.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $89.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $179.00K derived: sum of 2 quarters · filed 2023-11-14 | $208.00K 10-Q · filed 2023-11-14 | $257.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $90.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $119.00K 10-Q · filed 2023-08-14 | $168.00K derived: sum of 3 quarters · filed 2023-08-14 | $212.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $29.00K 10-Q · filed 2023-05-15 | $78.00K derived: sum of 2 quarters · filed 2023-05-15 | $122.00K derived: sum of 3 quarters · filed 2023-05-15 | |
| 2021-12-31 | $49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $93.00K derived: sum of 2 quarters · filed 2023-03-24 | $94.00K 10-K · filed 2023-03-24 | |
| 2021-09-30 | $44.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $45.00K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $1.00K 10-Q · filed 2022-08-22 | |||
| 2020-12-31 | $553.00K 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |